access intranet after hours circle-arrow apply blog caret circle arrow close closer look community outreach community outreach contact contact us down arrow facebook lock solid find a provider find a clinical trial find a provider find a researcher find faculty find-a-service how to apply join leadership left arrow locations logo make a gift map location maximize minimize my chart my chart notification hp notification lp next chevron right nxt prev pay your bill play previous quality and safety refer a patient request a speaker request appointment request an appointment residents corner rss search search jobs Asset 65 submit a story idea symptom checker Arrow Circle Up twitter youtube Dino Logo External Link University Logo Color University Logo Solid Health Logo Solid Arrow Right Circle Book Calendar Date Calendar Search Date Diploma Certificate Dollar Circle Donate Envelope Graduation Cap Map Pin Map Search Phone Pills Podcast

Interstitial Lung Disease (ILD) & Idiopathic Pulmonary Fibrosis (IPF)

Interstitial Lung Disease is a large group of lung disorders associated with inflammation and scarring of lung tissue. It is comprised of over 100 disorders that include Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, Sarcoidosis, Connective Tissue or Auto Immune related ILD and many others. The inflammation/scarring of this group of diseases decrease the lungs ability to receive oxygen. They are often symptomatic for shortness of breath and a dry cough. The diseases can be difficult to diagnose and vary from patient to patient. That is why the Interstitial Lung Disease Clinic at MUSC has the most current diagnostic and therapeutic modalities available. We take a multidisciplinary approach to the personalized care of our patients. 

Idiopathic Pulmonary Fibrosis is a type of chronic interstitial lung disease of unknown etiology characterized by the scarring of the lungs resulting in decreased lung function. Typical characteristics of the disease include progressive dyspnea, unproductive cough, and pulmonary insufficiency. It is more common in men than women.

Clinical Trials

 At MUSC our physicians have expertise in the diagnosis and differentiation of IPF. There is currently no known cure for the disease. MUSC is actively involved in research and clinical trials to identify treatments and therapies that may slow the progression IPF. View a list of currently enrolling clinical trials for patients with IPF. 

Our Care Team

More Care Team Members

Katie Shoptaw | ILD Nurs Coordinator